Ulf Stenestrand

7.2k total citations · 2 hit papers
62 papers, 4.8k citations indexed

About

Ulf Stenestrand is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ulf Stenestrand has authored 62 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ulf Stenestrand's work include Acute Myocardial Infarction Research (33 papers), Heart Failure Treatment and Management (18 papers) and Cardiac Imaging and Diagnostics (12 papers). Ulf Stenestrand is often cited by papers focused on Acute Myocardial Infarction Research (33 papers), Heart Failure Treatment and Management (18 papers) and Cardiac Imaging and Diagnostics (12 papers). Ulf Stenestrand collaborates with scholars based in Sweden, United Kingdom and United States. Ulf Stenestrand's co-authors include Lars Wallentin, Johan Lindbäck, Stefan James, Bo Lagerqvist, Tage Nilsson, Tomas Jernberg, Bo Lagerqvist, J. Carlsson, Kristina Hambræus and Anders Jeppsson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ulf Stenestrand

60 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

2007 871 citations Bo Lagerqvist, Stefan James et al. New England Journal of Medicine profile →
The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

2010 570 citations Tomas Jernberg, Stefan James et al. Heart profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulf Stenestrand Sweden	33	3.5k	2.1k	1.1k	451	354	62	4.8k
Eva Swahn Sweden	36	4.2k 1.2×	1.9k 0.9×	1.5k 1.4×	365 0.8×	325 0.9×	136	4.9k
Patrice Desvigne‐Nickens United States	33	3.5k 1.0×	1.9k 0.9×	787 0.7×	520 1.2×	173 0.5×	73	5.3k
Mattie Lenzen Netherlands	30	2.8k 0.8×	1.4k 0.6×	790 0.7×	561 1.2×	211 0.6×	121	3.8k
Usman Baber United States	36	3.3k 1.0×	2.4k 1.1×	1.0k 0.9×	817 1.8×	282 0.8×	193	5.7k
Omar Dabbous United States	33	3.8k 1.1×	1.7k 0.8×	1.3k 1.2×	181 0.4×	400 1.1×	119	6.0k
Kerry L. Lee United States	45	7.7k 2.2×	2.0k 0.9×	1.8k 1.7×	349 0.8×	643 1.8×	98	9.4k
Stefan Osswald Switzerland	45	6.2k 1.8×	2.3k 1.1×	1.6k 1.4×	610 1.4×	215 0.6×	305	7.6k
Suresh Mulukutla United States	33	2.7k 0.8×	2.0k 0.9×	1.1k 1.0×	482 1.1×	106 0.3×	166	4.3k
Hal V. Barron United States	34	4.6k 1.3×	1.6k 0.8×	1.2k 1.1×	332 0.7×	439 1.2×	81	6.1k
Vijay Kunadian United Kingdom	31	2.3k 0.7×	962 0.4×	670 0.6×	349 0.8×	232 0.7×	139	3.9k

Countries citing papers authored by Ulf Stenestrand

Since Specialization

Citations

This map shows the geographic impact of Ulf Stenestrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Stenestrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Stenestrand more than expected).

Fields of papers citing papers by Ulf Stenestrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Stenestrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Stenestrand. The network helps show where Ulf Stenestrand may publish in the future.

Co-authorship network of co-authors of Ulf Stenestrand

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Stenestrand. A scholar is included among the top collaborators of Ulf Stenestrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Stenestrand. Ulf Stenestrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janszky, Imre, Staffan Ahnve, Rickard Ljung, et al.. (2012). Daylight saving time shifts and incidence of acute myocardial infarction – Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Sleep Medicine. 13(3). 237–242. 71 indexed citations

Szummer, Karolina, Pia Lundman, Stefan H. Jacobson, et al.. (2011). Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney International. 79(9). 997–1004. 22 indexed citations

Huynh, Thao, John Birkhead, Kurt Huber, et al.. (2011). The Pre-Hospital Fibrinolysis Experience in Europe and North America and Implications for Wider Dissemination. JACC: Cardiovascular Interventions. 4(8). 877–883. 7 indexed citations

Hemingway, Harry, Martin Henriksson, Ruoling Chen, et al.. (2010). The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technology Assessment. 14(9). 1–151, iii. 38 indexed citations

Jernberg, Tomas, et al.. (2010). Effect of Angiotensin-Converting Enzyme Inhibition on One-Year Mortality and Frequency of Repeat Acute Myocardial Infarction in Patients With Acute Myocardial Infarction. The American Journal of Cardiology. 105(9). 1229–1234. 37 indexed citations

Lawesson, Sofia Sederholm, Ulf Stenestrand, Bo Lagerqvist, Lars Wallentin, & Eva Swahn. (2010). Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction. Heart. 96(6). 453–459. 62 indexed citations

Melander, Olle, Lars Wallentin, Johan Lindbäck, et al.. (2010). Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment. Journal of the American College of Cardiology. 55(13). 1362–1369. 49 indexed citations

Oldgren, Jonas, et al.. (2010). Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA. Heart. 96(18). 1451–1457. 17 indexed citations

Knot, Jiří, Petr Widimský, William Wijns, et al.. (2009). How to set up an effective national primary angioplasty network: lessons learned from five European countries.. PubMed. 5(3). 299, 301–309. 58 indexed citations

10.

James, Stefan, Ulf Stenestrand, Johan Lindbäck, et al.. (2009). Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden. New England Journal of Medicine. 360(19). 1933–1945. 178 indexed citations

11.

Szummer, Karolina, Pia Lundman, Stefan H. Jacobson, et al.. (2009). Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register. Journal of Internal Medicine. 268(1). 40–49. 131 indexed citations

12.

Carlsson, J., Stefan James, Johan Lindbäck, et al.. (2009). Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria. Journal of the American College of Cardiology. 53(16). 1389–1398. 22 indexed citations

13.

Englund, Anders, et al.. (2007). Influence of left bundle branch block on long-term mortality in a population with heart failure. European Heart Journal. 28(20). 2449–2455. 61 indexed citations

14.

Held, Claes, Per Tornvall, & Ulf Stenestrand. (2007). Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery. European Heart Journal. 28(3). 316–325. 21 indexed citations

15.

Lagerqvist, Bo, Stefan James, Ulf Stenestrand, et al.. (2007). Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden. New England Journal of Medicine. 356(10). 1009–1019. 871 indexed citations breakdown →

16.

Björklund, Erik, Ulf Stenestrand, Johan Lindbäck, et al.. (2005). Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI. Journal of Electrocardiology. 38(4). 186–186. 4 indexed citations

17.

Stenestrand, Ulf & Lars Wallentin. (2004). 1061-86 Underutilization of oral anticoagulation for atrial fibrillation in survivors of acute myocardial infarction influences long-term mortality. Journal of the American College of Cardiology. 43(5). A263–A263. 2 indexed citations

18.

Björklund, Erik, Bertil Lindahl, Ulf Stenestrand, et al.. (2004). Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. American Heart Journal. 148(4). 566–573. 44 indexed citations

19.

Stenestrand, Ulf, et al.. (2002). Prognostic importance of rest electrocardiogram for a large population of coronary care unit-patients (CCU) : a one year follow-up. European Heart Journal. 23. 112–112. 1 indexed citations

20.

DeBusk, Robert F., Ulf Stenestrand, Mary C. Sheehan, & William L. Haskell. (1990). Training effects of long versus short bouts of exercise in healthy subjects. The American Journal of Cardiology. 65(15). 1010–1013. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact